We are live on ! Find out more
MANE icon

Veradermics

165 hedge funds and large institutions have $4.17B invested in Veradermics in 2026 Q2 according to their latest regulatory filings, with 98 funds opening new positions, 41 increasing their positions, 19 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 98 | Existing positions closed: 14

263% more capital inflows, than outflows

Capital inflows: $1.08B | Capital outflows: $297M

116% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 19

104% more funds holding

Funds holding: 81 → 165 (+84)

60% more funds holding in top 10

Funds holding in top 10: 5 → 8 (+3)

7.23% more ownership

Funds ownership: 74.03% → 81.25% (+7.2%)

Holders
165
Holders Change
+84
Holders Change %
+103.7%
% of All Funds
1.96%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.1%
New
98
Increased
41
Reduced
19
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MANE Hedge Fund Activity: Q2 2026 in Review

165 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in Veradermics (MANE) for Q2 2026, worth a combined $4.17B — up 155% from $1.64B a quarter earlier.

Buyers outnumbered sellers: 98 funds opened new MANE positions and 14 closed out — a net gain of 84 holders — while 41 added to existing stakes and 19 trimmed.

The largest buyer was Deep Track Capital, adding an estimated $141M. The largest seller was Adage Capital Partners, cutting an estimated $51.5M.

  • 165 institutional investors held Veradermics (MANE) as of Q2 2026, up from 81 in Q1 2026.
  • Funds reported $4.17B of Veradermics stock for Q2 2026, up 155% quarter-over-quarter.
  • 98 funds opened new Veradermics positions in Q2 2026 and 14 closed out, a net change of +84 holders.
  • The largest Veradermics buyer in Q2 2026 was Deep Track Capital, an estimated $141M added.
  • The largest Veradermics seller in Q2 2026 was Adage Capital Partners, an estimated $51.5M sold.

Based on aggregated 13F filings for Q2 2026.